Laboratory Insight Report

Pandemic Readiness: Can Your Lab Sustain a Surge?

Laboratory leader perspectives on surge capacity, staffing endurance, supply resilience, LIS readiness and preparedness funding

Audience: Lab Managers / Supervisors / Directors

Countries: 2

Survey records: 10

-Hero findings

0 %
say their current team could sustain a high-volume emergency surge for only 2 to 4 weeks
Stockpiling leads shortage strategy. A 30 to 60 day surplus is the most selected reagent mitigation approach.
0 %
Cross-training is active. Routine bench staff can pivot across disciplines in a surge.
0 %
LIS confidence is strong. Half strongly agree public-health reporting can be automated.
0 %
Pandemic PCR assets stayed useful. High-throughput molecular infrastructure is fully integrated into routine testing.
0 %

– Quick Read — Key Findings

If testing demand doubled in 48 hours, what would fail first?

The full report follows the weak points lab leaders identify across supply, specimen logistics, staffing endurance, LIS readiness and funding durability.

Preparedness is not a machine on standby. It is a system that can keep functioning under sustained demand.

CDC’s Laboratory Response Network is built around rapid testing, secure reporting, training and surge capability during public health emergencies. The MDForLives laboratory responses point to the same reality at an institutional level: readiness depends on more than molecular platforms. It also depends on reagents, specimen logistics, cross-trained staff, information systems and funding that survives the quiet years between crises.

Clinical context: CDC describes laboratory preparedness as an integrated capability that includes testing capacity, trained personnel, secure reporting, readiness exercises and the ability to support surge demand during public health emergencies.

MDForLives captured perspectives from Lab Managers / Supervisors / Directors across United States, Canada. The findings below focus on the operational and clinical patterns that stand out across the response data.

If testing demand doubled in 48 hours, what would fail first?
The question behind the report

The first failure point is split between supply and specimen flow

When asked what would limit a 48-hour doubling of molecular throughput, respondents divide between reagent availability and specimen collection or transport.

What the pattern suggests: The bottleneck is not necessarily the analyzer. Capacity can be stranded upstream by collection logistics or downstream by supply and data flow.

 

Why it matters: Surge planning should map the complete diagnostic pathway, from collection to reporting, instead of measuring readiness by instrument count alone.

Half of pandemic-era molecular capacity found a permanent job

The strongest infrastructure signal is not mothballing. It is repurposing.

What the pattern suggests: Repurposing surge assets into respiratory panels, STI testing or other routine work can preserve staff familiarity and justify maintenance costs.

 

Why it matters: Infrastructure that earns its place in routine operations is easier to keep ready for the next surge.

The information layer looks stronger than the funding layer

Most respondents view their LIS reporting capability positively, even while dedicated preparedness funding appears fragile.

What the pattern suggests: Digital reporting may be one of the better-preserved pieces of readiness in this small sample.

 

Why it matters: A capable LIS reduces the administrative drag of a surge, but it cannot compensate for missing staff, reagents or maintenance budgets.

Supply resilience is still being bought as inventory

The most common shortage strategy is a 30 to 60 day surplus rather than platform diversification.

What the pattern suggests: Inventory is the most immediate hedge, but it has storage, expiry and financing costs.

 

Why it matters: Long-term resilience may require a portfolio approach that combines stock, vendor flexibility, alternative methods and validated backup workflows.

Cross-training is common, but workforce endurance is short

Most respondents report active cross-training, yet the same group signals that sustained surge staffing remains a vulnerability.

What the pattern suggests: Cross-training improves elasticity, but it does not create additional people. A surge can still exhaust a flexible team if baseline staffing is thin.

 

Why it matters: Preparedness plans need both skill mobility and staffing depth, including relief, retention and backup coverage.

Preparedness budgets are the most fragile layer

Only one respondent reports readiness as an explicitly funded priority.

What the pattern suggests: The quiet period after a crisis creates a predictable governance problem: preparedness looks expensive precisely when it is not being visibly used.

 

Why it matters: Readiness degrades gradually through expired stock, lapsed service contracts, staff turnover and lost competency long before the next emergency makes the gap obvious.

What respondents said when the answer choices disappeared

Supply chain resilience must be maintained between crises

Open comments return to reagent, PPE and vendor vulnerabilities, including the need for diversified supply and maintained stockpiles.

Laboratory capacity is broader than analyzer capacity

Respondents describe staffing, consumables, collection supplies and partnerships as part of the same readiness system.

Workforce endurance is a preparedness asset

Retention, cross-training and the physical and mental strain of sustained demand appear alongside technical capacity.

Preparedness should stay funded in non-crisis periods

The clearest qualitative warning is that resilience erodes when stockpiles, backup equipment and staffing investments are treated as temporary emergency costs.

What this tells us

Readiness is a system, not an analyzer

Reagents, specimen flow, reporting, staffing and backup capacity fail together when one layer is weak.

Cross-training creates elasticity

A workforce that can move across benches gives laboratories more room to absorb sudden volume.

Preparedness erodes between crises

Service contracts, inventory and workforce investment are easiest to cut precisely when they are least visible.

Pandemic Readiness: Can Your Lab Sustain a Surge?

These laboratory responses suggest that preparedness can remain technically capable while becoming operationally fragile. Molecular assets and LIS capability may stay in place even as funding and workforce endurance weaken. The next diagnostic surge will test whether hospitals preserved a complete readiness system, not simply the instruments purchased during the last crisis.

// at a glance
Total Survey Records
10
Countries Covered
2
Specialty
Lab Managers
Published Date
13 July 2026
Completion Rate
70%
Survey ID
8914810
// browse categories

You have read the summary

The findings go deeper.
So can your participation.

Discover the complete research behind these insights, or become part of future studies with MDForLives.

Frequently asked questions

What does laboratory pandemic preparedness include?

Preparedness includes validated testing methods, trained staff, surge workflows, supply continuity, specimen logistics, biosafety, data reporting and the ability to scale operations during an emergency.

Routine capacity is optimized for expected volume. Surge capacity must absorb sudden demand while maintaining turnaround time, quality and safety, often with disrupted supply chains and rapidly changing testing requirements.

Cross-training gives laboratories more flexibility to redeploy staff when one discipline experiences a sudden volume spike. It works best when competencies are maintained and credentialing or scope requirements are addressed before an emergency.

The laboratory information system supports order intake, result management and electronic reporting. Automated interfaces can reduce manual entry and speed notification, but they still depend on reliable data standards and connections with public health systems.

Keeping equipment maintained, serviced and occasionally used can preserve readiness while avoiding the cost of running full surge capacity every day. The trade-off is the ongoing expense of service contracts, competency and quality control.

Common strategies include safety stock, multiple suppliers or platforms, validated alternative methods, vendor agreements and coordinated regional partnerships. The right mix depends on storage, shelf life, regulatory requirements and local risk.

Direct answers to the questions healthcare professionals are most likely to ask about these findings.

Scroll to Top